Boston Partners reduced its stake in shares of Orchids Paper Products (NYSEAMERICAN:TIS) by 2.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 225,099 shares of the basic materials company’s stock after selling 5,978 shares during the quarter. Boston Partners’ holdings in Orchids Paper Products were worth $2,881,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently modified their holdings of the company. Rhumbline Advisers lifted its holdings in shares of Orchids Paper Products by 6.8% in the second quarter. Rhumbline Advisers now owns 10,092 shares of the basic materials company’s stock valued at $131,000 after purchasing an additional 646 shares in the last quarter. TIAA CREF Investment Management LLC lifted its holdings in shares of Orchids Paper Products by 4.7% in the second quarter. TIAA CREF Investment Management LLC now owns 24,304 shares of the basic materials company’s stock valued at $315,000 after purchasing an additional 1,090 shares in the last quarter. Parametric Portfolio Associates LLC purchased a new stake in shares of Orchids Paper Products in the second quarter valued at about $549,000. NJ State Employees Deferred Compensation Plan lifted its holdings in shares of Orchids Paper Products by 73.3% in the third quarter. NJ State Employees Deferred Compensation Plan now owns 52,000 shares of the basic materials company’s stock valued at $732,000 after purchasing an additional 22,000 shares in the last quarter. Finally, GSA Capital Partners LLP purchased a new stake in shares of Orchids Paper Products in the third quarter valued at about $1,262,000.

Orchids Paper Products (NYSEAMERICAN TIS) opened at $11.19 on Thursday. The stock has a market cap of $116.70, a P/E ratio of 279.75 and a beta of 1.15. Orchids Paper Products has a one year low of $8.31 and a one year high of $30.38.

Several equities analysts recently issued reports on the stock. TheStreet raised shares of Orchids Paper Products from a “d+” rating to a “c-” rating in a research note on Thursday, November 30th. Zacks Investment Research raised shares of Orchids Paper Products from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 26th.

WARNING: “Orchids Paper Products (TIS) Holdings Trimmed by Boston Partners” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another publication, it was illegally stolen and republished in violation of US and international copyright and trademark laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2018/02/15/orchids-paper-products-tis-holdings-trimmed-by-boston-partners.html.

Orchids Paper Products Company Profile

Orchids Paper Products Company is a supplier of consumer tissue products. The Company produces bulk tissue paper, known as parent rolls, and converts parent rolls into finished products, including paper towels, bathroom tissue and paper napkins. The Company offers customers a range of private label products across the value, premium and ultra-premium market segments.

Want to see what other hedge funds are holding TIS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orchids Paper Products (NYSEAMERICAN:TIS).

Institutional Ownership by Quarter for Orchids Paper Products (NYSEAMERICAN:TIS)

Receive News & Ratings for Orchids Paper Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orchids Paper Products and related companies with MarketBeat.com's FREE daily email newsletter.